- Tytuł:
- A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
- Autorzy:
- Źródło:
- PharmacoEconomics. 41(8):945-980
Czasopismo naukowe